Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis

BACKGROUND: Naltrexone is an opioid antagonist used in many different conditions, both licensed and unlicensed. It is used at widely varying doses from 3 to 250 mg. The aim of this review was to extensively evaluate the safety of oral naltrexone by examining the risk of serious adverse events and ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolton, Monica, Hodkinson, Alex, Boda, Shivani, Mould, Alan, Panagioti, Maria, Rhodes, Sarah, Riste, Lisa, van Marwijk, Harm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332608/
https://www.ncbi.nlm.nih.gov/pubmed/30642329
http://dx.doi.org/10.1186/s12916-018-1242-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332608/
https://www.ncbi.nlm.nih.gov/pubmed/30642329
http://dx.doi.org/10.1186/s12916-018-1242-0

Ejemplares similares